<DOC>
	<DOC>NCT02585440</DOC>
	<brief_summary>This is a phase 1 study to evaluate the safety and tolerability of multiple oral doses of CMX157 at increasing dose levels.</brief_summary>
	<brief_title>A Multiple Dose Study of the Safety, Tolerability and PK of CMX157 in Healthy Subjects</brief_title>
	<detailed_description>This is a phase 1 study to evaluate the safety and tolerability of multiple oral doses of CMX157 at increasing dose levels, in a fasted state and a fed state.</detailed_description>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<criteria>Age: 1855. Capable of giving written informed consent. Capable of completing study requirements. Positive result for HIV, HBV, or HCV. History or medical condition which could impact patient safety. Current or past abuse of alcohol or illicit drugs. Participation in another clinical trial within the past 30 days.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>